glp 1 optic nerve Small NAION Risk from GLP-1 Therapy Not Yet Worth Drug Discontinuation, Experts Say Do GLP-1 Medications Cause Eye

Both wild-type and hepsin / mice received an intraperitoneal injection of 2APB (20 mg/kg), followed by a dose of APAP (500 mg/kg) 2 h later (Fig

& Ginsberg, D

Urgent situations requiring immediate medical attention include: Severe, persistent abdominal pain (with or without vomiting), which may indicate pancreatitis Signs of gallbladder disease (right upper quadrant pain, nausea) Persistent vomiting leading to inability to keep fluids down or signs of dehydration Specific situations requiring consultation include: Persistent gastrointestinal symptoms (nausea, vomiting, diarrhea) lasting beyond the initial adjustment period Unintended weight loss exceeding clinical targets or occurring too rapidly Signs of nutritional deficiency such as fatigue, weakness, hair loss, brittle nails, or neurological symptoms Difficulty meeting protein or caloric needs through diet alone Consideration of high-dose supplements or specialized nutritional products Use of multiple supplements or herbal products with potential interactions Need for medication adjustments if also taking insulin or sulfonylureas to prevent hypoglycemia Patients who are pregnant, planning pregnancy, or breastfeeding should discuss all medications and supplements with their healthcare provider, as certain products may be contraindicated

For most healthy adults, it is reasonably well tolerated

The COA should include batch numbers matching the product received and testing from recognized laboratories